OTC Bronchodilators With Ephedrine Permitted In New Proposed Rule
This article was originally published in The Tan Sheet
Executive Summary
Additional warnings and other revised labeling would be required for bronchodilator products containing ephedrine or epinephrine under an FDA proposed rule published in the July 13 Federal Register
You may also be interested in...
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management